Real world treatment patterns and healthcare resource utilization (HRU) among chronic lymphocytic leukemia (CLL) patients by regimen.

被引：0

作者：

Byfield, Stacey DaCosta

Korrer, Stephanie

Ellis, Lorie

Schenkel, Brad

机构：

[1] OptumInsight, Eden Prairie, MN USA

[2] Optum, Eden Prairie, MN USA

[3] Janssen Sci Affairs LLC, Horsham, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.e18043

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e18043

引用

页数：1

共 50 条

[1] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
Schenkel, Brad
Ellis, Lorie
Korrer, Stephanie
Byfield, Stacey DaCosta
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
[2] Real world treatment patterns, adverse events and healthcare resource utilization and costs among chronic lymphocytic leukemia (CLL) patients in the US
Kabadi, Shaum
Olufade, Temitope O.
Le, Lisa
Byfield, Stacey Dacosta
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 78 - 79
[3] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
Rogers, Kerry Anne
Emond, Bruno
Manceur, Ameur M.
Kinkead, Frederic
Lafeuille, Marie-Helene
Lefebvre, Patrick
Huang, Qing
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[4] Real World Treatment Patterns, Adverse Events and Healthcare Resource Utilization and Costs Among Chronic Lymphocytic Leukemia (CLL) Patients in the United States
Kabadi, Shaum
Le, Lisa
Byfield, Stacey Dacosta
Olufade, Temitope O.
BLOOD, 2018, 132
[5] Healthcare Resource Utilization (HRU) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Kozma, Chris
Slaton, Terra
McKenzie, Scott
Ellis, Lone
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S132 - S132
[6] Real-World Treatment Patterns, Adherence and Healthcare Resource Utilization for Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Among Veterans in the United States
Yang, Keri
Liu, Sizhu
Tang, Boxiong
Chanan-Khan, Asher
BLOOD, 2021, 138
[7] EFFECT OF EARLIER USE OF IBRUTINIB ON HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) IN THE UNITED STATES
Challagulla, S.
Lee, P.
Giafis, N.
Manceur, A. M.
Fakih, I
Emond, B.
Iyengar, R.
VALUE IN HEALTH, 2021, 24 : S37 - S37
[8] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS RECEIVING TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
Weil, C.
Chodick, G.
Shalev, V
Kan, I
Afik, R.
Cohen, R.
Sail, K.
VALUE IN HEALTH, 2019, 22 : S412 - S413
[9] Real-World Evaluation of Treatment Discontinuation and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chanan-Khan, Asher Alban
Challagulla, Swetha
Donckels, Elizabeth
Chuang, Po-Ya
Yang, Keri
BLOOD, 2023, 142
[10] Understanding real world treatment patterns, healthcare resource utilization (HRU) and costs among metastatic renal cell carcinoma (mRCC) patients
Copher, R.
Byfield, S. Dacosta
Buzinec, P.
Korrer, S.
Baig, M.
ANNALS OF ONCOLOGY, 2016, 27

← 1 2 3 4 5 →